BioPhorum
Connect
||
Collaborate
||
Accelerate

Since its inception in 2004, BioPhorum has become the open and trusted environment where senior leaders of the biopharmaceutical industry come together to openly share and discuss the emerging trends and challenges facing their industry.

Growing from an end-user group in 2008, BioPhorum now comprises over 120 manufacturers and suppliers deploying their top 5000 leaders and subject matter experts to work in eight focused Phorums, articulating the industry’s technology roadmap, defining the supply partner practices of the future, and developing and adopting best practices in drug substance, fill finish, process development and manufacturing IT.

BioPhorum Guided Facailitation InfoGraphic

Newsletter subscribe

Enter your E-mail address to receive our monthly newsletter direct to your inbox.

This field is for validation purposes and should be left unchanged.

You can unsubscribe at any time to clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

Recent releases

biophorum post images website images jan 2022 draft 223
Jan 09 2022

Addressing the challenges of using RNA as a therapeutic or a gene-editing tool

RNA technologies, including mRNA therapeutics, have emerged as a promising drug modality due to their essential biological role in protein expression and their...
biophorum post images website images december 20213 222
Jan 09 2022

Supporting particle investigations with risk-based decision-making

BioPhorum’s Visual Inspection workstream has invested considerable time and effort to add clarity to the uncertainty around how to assess the risk of atypical particles...
biophorum post images website images jan 2022 draft3 221
Jan 09 2022

Using a closure analysis method to reduce CGT contamination risks

Many cell therapy manufacturing processes use open unit manipulations. As a result, they are at risk of potential contamination that can result in manufacturing batch...
biophorum post images website images jan 2022 draft4 219
Jan 09 2022

Bridging the worlds of IT and CGT through analogies

Cell and gene therapies (CGTs) have enormous potential to create personalized therapeutics for patients with diseases that were once untreatable – but they come with...
biophorum post images website images december 2021 211
Nov 30 2021

How to replenish working cell banks with a risk-based scientific approach

Cell banks represent the fundamental starting substrates for biological drug substance/drug substance intermediate manufacturing. So, the availability of...
biophorum post images website images december 20217 210
Nov 30 2021

How to make in-use stability and compatibility studies a success

In-use stability and compatibility studies are often used in biotherapeutic development to assess biologic drugs with diluents and/or administration components. The...

A powerful vehicle for change

BioPhorum facilitators bring leaders together to create future visions, mobilize teams of experts on the opportunities, create partnerships that enable change and provide the quickest route to implementation, so that the industry shares, learns and builds the best solutions together.

LONG READ

Chain reaction: how the biopharmaceutical supply chain survived the pandemic

Read more

Our mission

Bringing leaders together

to create future visions that focus the industry’s energy on the key emerging opportunities

Mobilizing communities

of the top experts around these opportunities, up and down the biopharma value chain

Creating partnerships

that enable change and provide the quickest route to implementation and results

Replacing isolation

with collaboration so that the industry shares, learns and
builds the best solutions together

Work with us

BioPhorum is a global collaboration of industry leaders and subject matter experts working together to pool knowledge, practices, and ideas, which lead to results that effect real change.